Christopher Gibson Recursion Pharmaceuticals, Inc. (RXRX) insider trading activity

RXRX Quotes by TradingView

Christopher Gibson is Chief Executive Officer of RECURSION PHARMACEUTICALS, INC.. Currently has a direct ownership of 954,229 shares of RXRX, which is worth approximately $5.24 Million. The most recent transaction as insider was on Apr 20, 2021, when has been sold 9,317,883 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 954K
11.75% 3M change
25.12% 12M change
Total Value Held $5.24 Million

Christopher Gibson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 20 2021
SELL
Other acquisition or disposition
-
9,317,883 Reduced 100.0%
0 Common Stock
Apr 20 2021
BUY
Conversion of derivative security
-
55,383 Added 0.59%
9,317,883 Common Stock
Apr 20 2021
BUY
Other acquisition or disposition
-
9,317,883 Added 50.0%
9,317,883 Class B Common Stock
CG

Christopher Gibson

Chief Executive Officer
Salt Lake City, UT

Track Institutional and Insider Activities on RXRX

Follow RECURSION PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RXRX shares.

Notify only if

Insider Trading

Get notified when an Recursion Pharmaceuticals, Inc. insider buys or sells RXRX shares.

Notify only if

News

Receive news related to RECURSION PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RXRX